Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Vallard

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Oncology|June 21, 2019
Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort StudyAlexis Vallard, Stéphanie Morisson, Fabien Tinquaut, et al.
International Journal of Cardiology|April 10, 2017
Atrial fibrillation in cancer patients: Hindsight, insight and foresightBenoîte Mery, Jean-Baptiste Guichard, Jean-Baptiste Guy, et al.
Chinese Journal of Cancer|July 15, 2017
Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?Alexis Vallard, Chloé Rancoule, Jean-Baptiste Guy, et al.
Bulletin Du Cancer|December 24, 2019
[Radiotherapy and immune suppression: A short review]Claire Bosacki, Alexis Vallard, Omar Jmour, et al.
Bulletin Du Cancer|December 23, 2019
[Stereotactic body radiotherapy: Passing fad or revolution?]Alexis Vallard, Nicolas Vial, Omar Jmour, et al.
Critical Reviews in Oncology/Hematology|March 23, 2017
Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospectsRomain Rivoirard, Aurélie Bourmaud, Mathieu Oriol, et al.
Critical Reviews in Oncology/Hematology|October 9, 2018
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategiesMing Yuan He, Chloé Rancoule, Amel Rehailia-Blanchard, et al.
British Journal of Cancer|June 26, 2020
Radiation-induced bystander and abscopal effects: important lessons from preclinical modelsElisabeth Daguenet, Safa Louati, Anne-Sophie Wozny, et al.
Bulletin Du Cancer|January 9, 2019
[Innovation in radiotherapy: A glance at 2018]Nicolas Vial, Alexis Vallard, Omar Jmour, et al.
Chemotherapy|January 12, 2016
Real-World Outcomes of Combination Chemotherapy with Trabectedin plus Pegylated Liposomal Doxorubicin in Patients with Recurrent Ovarian Cancer: A Single-Center ExperienceGuillaume Moriceau, Romain Rivoirard, Benoîte Méry, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Oncology|June 21, 2019
Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort StudyAlexis Vallard, Stéphanie Morisson, Fabien Tinquaut, et al.
International Journal of Cardiology|April 10, 2017
Atrial fibrillation in cancer patients: Hindsight, insight and foresightBenoîte Mery, Jean-Baptiste Guichard, Jean-Baptiste Guy, et al.
Chinese Journal of Cancer|July 15, 2017
Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?Alexis Vallard, Chloé Rancoule, Jean-Baptiste Guy, et al.
Bulletin Du Cancer|December 24, 2019
[Radiotherapy and immune suppression: A short review]Claire Bosacki, Alexis Vallard, Omar Jmour, et al.
Bulletin Du Cancer|December 23, 2019
[Stereotactic body radiotherapy: Passing fad or revolution?]Alexis Vallard, Nicolas Vial, Omar Jmour, et al.
Critical Reviews in Oncology/Hematology|March 23, 2017
Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospectsRomain Rivoirard, Aurélie Bourmaud, Mathieu Oriol, et al.
Critical Reviews in Oncology/Hematology|October 9, 2018
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategiesMing Yuan He, Chloé Rancoule, Amel Rehailia-Blanchard, et al.
British Journal of Cancer|June 26, 2020
Radiation-induced bystander and abscopal effects: important lessons from preclinical modelsElisabeth Daguenet, Safa Louati, Anne-Sophie Wozny, et al.
Bulletin Du Cancer|January 9, 2019
[Innovation in radiotherapy: A glance at 2018]Nicolas Vial, Alexis Vallard, Omar Jmour, et al.
Chemotherapy|January 12, 2016
Real-World Outcomes of Combination Chemotherapy with Trabectedin plus Pegylated Liposomal Doxorubicin in Patients with Recurrent Ovarian Cancer: A Single-Center ExperienceGuillaume Moriceau, Romain Rivoirard, Benoîte Méry, et al.
Pageof 10